News Release

Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial

Peer-Reviewed Publication

PLOS

Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial

image: Researchers find that self-help metacognitive therapy significantly reduces anxiety and depression symptoms in recovering heart disease patients. view more 

Credit: Hassan OUAJBIR, Pexels (CC0, https://creativecommons.org/publicdomain/zero/1.0/)

Self-help metacognitive therapy – which aims to reduce rumination – significantly reduces anxiety and depression symptoms in recovering heart disease patients, according to new randomized controlled trial

 

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004161

Article Title: Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial

 

Author Countries: United KingdomFunding: This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR) Programme (Grant Reference Number RP-PG-1211-20011). AW was awarded the grant. https://fundingawards.nihr.ac.uk/award/RP-PG-1211-20011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.